PREVAC: Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19: Coronavirus – COVID-19

2021 OCT 27 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Daily -- Staff editors report on the newly launched clinical trial, NCT05075941, which has the following summary description: “The main objective of the study is to assess the level of vaccination coverage (VC) against COVID-19 among migrants, homeless and travelling community, according to their living conditions and housing. The secondary objectives are : - to compare the estimated level of vaccination coverage in the different sites and strata (emergency shelters/hotels, camps, workers’ hostels, on the street) with the estimated level in the general population of the same territory obtained from the French Health Insurance data (SIVAC). - identify the obstacles and leverage of vaccination (i.e. mobile team) according to living conditions and habitat (socio-demographic factors, personal health history, vaccine adherence, local health policies, etc.).”

As a matter of record, on October 14, 2021, NewsRx staff editors report that the available information provided by Epicentre on this trial include:

Tracking Information

Descriptive Information

Recruitment Information

Administrative Information

(Our reports deliver fact-based news of research and discoveries from around the world.)